Pronóstico del mercado de tratamiento de sarcopenia en Oriente Medio y África hasta 2030 – Análisis regional – por tipo de tratamiento (suplemento de vitamina D y calcio, suplemento de proteína, suplemento de vitamina B12 y otros) y canal de distribución (farmacias, canales minoristas, canales en línea y otros)
La creciente conciencia sobre la sarcopenia refuerza el mercado de tratamiento de sarcopenia en Oriente Medio y África
La creciente conciencia sobre la sarcopenia y su impacto negativo en la salud presenta un margen significativo para avances en los campos de la atención sanitaria y geriátrica. Muchos grupos y organizaciones de defensa están tomando medidas de manera proactiva para crear conciencia sobre la sarcopenia entre las masas. Estas organizaciones suelen trabajar con profesionales médicos para mantener al público actualizado sobre los diversos aspectos de ciertos trastornos, como la patogenicidad, los pacientes objetivo, la prevención y los tratamientos, además de subrayar el valor de un diagnóstico y tratamiento rápidos. En línea con la campaña \"Más fuerte que la sarcopenia\" de OWH, se insta a las mujeres a hablar sobre la sarcopenia con sus proveedores de atención médica, y luego someterse a exámenes de detección de la enfermedad y tomar la terapia adecuada si es necesario.
La sarcopenia se ha incluido en los planes de estudio de las facultades de medicina y en los programas de formación para profesionales de la salud, como médicos, enfermeras y fisioterapeutas. Por ejemplo, la OWH trabajó con Medscape Education para crear créditos de educación médica continua (CME) para profesionales de la salud, lo que los equipará mejor para detectar y tratar la sarcopenia en sus pacientes. Los principales medios de comunicación han ampliado su cobertura de la sarcopenia para incluir artículos, noticias y documentales. Por lo tanto, es probable que la mayor conciencia sobre la sarcopenia traiga nuevas tendencias de crecimiento al mercado del tratamiento de la sarcopenia en los próximos años.
Descripción general del mercado de tratamiento de sarcopenia en Oriente Medio y África
El mercado de tratamiento de sarcopenia en Oriente Medio y África está segmentado en Arabia Saudita, los Emiratos Árabes Unidos, Sudáfrica y el resto de MEA. Los Emiratos Árabes Unidos y Arabia Saudita se encuentran entre los contribuyentes más importantes al mercado debido a la creciente incidencia de trastornos ortopédicos. La mayor conciencia entre la gran población sobre el uso y los beneficios de los suplementos nutricionales también beneficia el progreso del mercado.
Un mayor riesgo de sarcopenia en Sudáfrica está asociado con el envejecimiento de la población y la inadecuada seguridad alimentaria y la ingesta de nutrientes provocadas por la pobreza. Se prevé que el mercado del tratamiento de la sarcopenia en este país estará impulsado por un enfoque poblacional distinto adoptado por las autoridades sanitarias para el diagnóstico, tratamiento y prevención de la sarcopenia.
Ingresos del mercado de tratamiento de sarcopenia en Oriente Medio y África y pronóstico hasta 2030 (millones de dólares estadounidenses)
Segmentación del mercado de tratamiento de sarcopenia en Oriente Medio y África
Tratamiento de sarcopenia en Oriente Medio y África El mercado se clasifica en tipo de tratamiento, canal de distribución y país.
Según el tipo de tratamiento, el mercado de tratamiento de la sarcopenia en Oriente Medio y África se segmenta en suplementos de vitamina D y calcio, suplementos proteicos, suplementos de vitamina B12 y otros. El segmento de suplementos de vitamina D y calcio tuvo la mayor participación de mercado de tratamiento de sarcopenia en Medio Oriente y África en 2022.
En términos de canal de distribución, el mercado de tratamiento de sarcopenia en Medio Oriente y África está segmentado en farmacias, canales minoristas y en línea. canales y otros. El segmento de farmacias tuvo la mayor participación de mercado de tratamiento de sarcopenia en Medio Oriente y África en 2022.
Por país, el mercado de tratamiento de sarcopenia en Medio Oriente y África está segmentado en Arabia Saudita, Sudáfrica, los Emiratos Árabes Unidos y el resto de Medio Oriente y África. Sudáfrica dominó la cuota de mercado del tratamiento de la sarcopenia en Oriente Medio y África en 2022.
Abbott Laboratories, Bayer AG, Nestlé Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp y GSK Plc son algunos de las empresas líderes que operan en el mercado de tratamiento de sarcopenia en Oriente Medio y África.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Sarcopenia Treatment Market - Key Industry Dynamics
4.1 Middle East & Africa Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
5.2 Middle East & Africa Sarcopenia Treatment Market Forecast and Analysis
6. Middle East & Africa Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement: Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Sarcopenia Treatment Market - Country Analysis
8.1 Middle East & Africa
8.1.1 Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 South Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 South Africa Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 South Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 Saudi Arabia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 Saudi Arabia Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 Saudi Arabia Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 United Arab Emirates Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 United Arab Emirates Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 United Arab Emirates Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.5 Rest of Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.5.1 Rest of Middle East & Africa Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.5.2 Rest of Middle East & Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Nestle Health Science SA
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Novartis AG
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Pfizer Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Sanofi SA
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Amway Corp
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 GSK Plc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Middle East & Africa Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
Table 4. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
Table 5. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
Table 6. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Country
Table 7. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
Table 8. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
Table 9. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
Table 10. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
Table 11. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
Table 12. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
Table 13. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
Table 14. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
Table 15. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 16. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 17. Glossary of Terms, Sarcopenia Treatment Market
List of Figures
Figure 1. Middle East & Africa Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Middle East & Africa Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
Figure 4. Middle East & Africa Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement: Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Middle East & Africa Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Middle East & Africa Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. Middle East & Africa Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn)
Figure 17. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn)
Figure 18. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 19. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 20. Growth Strategies in the Sarcopenia Treatment Market
1. Abbott Laboratories
2. Bayer AG
3. Nestle Health Science SA
4. Novartis AG
5. Pfizer Inc
6. Sanofi SA
7. Amway Corp
8. GSK Plc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa sarcopenia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa sarcopenia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.